Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contraceptive vaginal ring.

Tessa Madden1, Paul Blumenthal

  • 1Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri 63110, USA. maddent@wustl.edu

Clinical Obstetrics and Gynecology
|November 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Centenarians' views and experiences of longevity: a meta-ethnographic systematic review.

The Gerontologist·2026
Same author

Pilot randomized control trial assessing interpersonal quality of contraceptive counseling via telephone vs video.

Contraception·2025
Same author

Hormonal Contraception Use and Risk of Lower Urinary Tract Symptoms and Conditions: Findings From the Boston Area Community Health Survey.

International urogynecology journal·2025
Same author

Use of PROMIS Global-10 to measure changes in health-related quality of life among contraceptive initiators: A feasibility study.

Contraception·2025
Same author

Abortion trends in Southern Illinois after the Dobbs vs Jackson Women's Health Organization decision.

American journal of obstetrics and gynecology·2025
Same author

The 2024 US Medical Eligibility Criteria for Contraceptive Use: Application to Practice in the Care of Patients With Cardiac Disease.

Circulation research·2025
Same journal

Obstetric Care for Patients With Cognitive Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Dissecting the Americans With Disabilities Act (ADA) Requirements when Approaching Obstetric Patients With Disabilities: How to Ensure Your Spaces are Accessible for All.

Clinical obstetrics and gynecology·2026
Same journal

Clinician Comfort and Barriers to the Obstetric and Gynecologic Care of Patients With Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Obstetric Care for Patients With Visual Impairments: Preconception Counseling Through Postpartum Care.

Clinical obstetrics and gynecology·2026
Same journal

Menstrual Management and Contraception for Patients With Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Favoring Elective Hospitalization in Pregnancies With Vasa Previa.

Clinical obstetrics and gynecology·2026
See all related articles

The vaginal contraceptive ring, approved in 2001, offers high efficacy for preventing pregnancy. Its effectiveness in real-world use is comparable to clinical trial results, making it a reliable birth control option.

Area of Science:

  • Reproductive Health
  • Contraception
  • Endocrinology

Background:

  • The vaginal contraceptive ring is a hormonal birth control method.
  • It utilizes a combination of ethinyl estradiol and etonorgestrel.

Purpose of the Study:

  • To evaluate the efficacy and effectiveness of the vaginal contraceptive ring.
  • To provide an overview of its approval and performance.

Main Methods:

  • Analysis of clinical trial data and real-world usage statistics.
  • Assessment of the Pearl Index as a measure of efficacy.

Main Results:

  • The vaginal contraceptive ring demonstrates high efficacy with a Pearl Index of 1.18.
  • Achieved a 99.1% efficacy rate in clinical settings.

Related Experiment Videos

  • Effectiveness in actual use is comparable to theoretical effectiveness.

    • Conclusions:

    • The vaginal contraceptive ring is a highly effective contraceptive method.
    • Its real-world effectiveness supports its use for pregnancy prevention.
    • Approved by the FDA in 2001, it remains a significant option in reproductive health.